BA
Barclays PLC disclosed a 5.5% stake in ALDX
Barclays PLC reported owning 5.5% of Aldeyra Therapeutics, Inc. (ALDX) (3,310,587 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G